Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.45 |
| ▸ | SSTR4 | P31391 | 3/20 | 0.44 |
| ▸ | REN | P00797 | 15/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30149615 | 1.00 | SLC6A2 (0.45) | SLC6A2SLC6A4SLC6A3SSTR4REN | |
| Hydrochloric Acid SCHEMBL15010249 | 0.98 | SLC6A2 (0.46) | SLC6A2SLC6A4SLC6A3SSTR4REN | |
| SCHEMBL31470376 | 0.89 | SSTR4 (0.39) | SLC6A2SLC6A4SLC6A3SSTR4REN | |
| Hydrochloric Acid SCHEMBL31470354 | 0.87 | SLC6A2 (0.39) | SLC6A2SLC6A4SLC6A3SSTR4REN | |
| SCHEMBL23219939 | 0.82 | REN (0.46) | SSTR4REN | |
| SCHEMBL16471470 | 0.82 | REN (0.46) | SSTR4REN | |
| SCHEMBL16471469 | 0.82 | REN (0.46) | SSTR4REN | |
| SCHEMBL4289942 | 0.80 | REN (0.41) | SSTR4REN | |
| Hydrochloric Acid SCHEMBL3598524 | 0.79 | REN (0.41) | SSTR4REN | |
| SCHEMBL5170092 | 0.79 | REN (0.44) | SSTR4REN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116102700-B | Softening agent and preparation method thereof | 江苏奥斯佳材料科技股份有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-116285775-A | High-performance chloroprene rubber adhesive and preparation method thereof | 上谷新材料(苏州)有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-116102700-A | Softening agent and preparation method thereof | 江苏奥斯佳材料科技股份有限公司 | 2023-05-12 | — | — | CN | claimed |
| CN-112961303-B | Softening agent for soft polyurethane foam and application thereof | 江苏奥斯佳材料科技股份有限公司 | 2023-01-03 | — | — | CN | claimed |
| CN-119505154-A | Special cross-linking agent for flexible polyurethane foam and application thereof | 奥斯佳新材料技术研究(江苏)有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-116102700-B | Softening agent and preparation method thereof | 江苏奥斯佳材料科技股份有限公司 | 2024-12-10 | — | — | CN | disclosed |
| CN-116120515-B | Flexible polyurethane foam and method for producing the same | 江苏奥斯佳材料科技股份有限公司 | 2024-12-10 | — | — | CN | disclosed |
| CN-116285775-A | High-performance chloroprene rubber adhesive and preparation method thereof | 上谷新材料(苏州)有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-116120515-A | Flexible polyurethane foam and method for producing the same | 江苏奥斯佳材料科技股份有限公司 | 2023-05-16 | — | — | CN | disclosed |
| CN-116102700-A | Softening agent and preparation method thereof | 江苏奥斯佳材料科技股份有限公司 | 2023-05-12 | — | — | CN | disclosed |
| CN-112961303-B | Softening agent for soft polyurethane foam and application thereof | 江苏奥斯佳材料科技股份有限公司 | 2023-01-03 | — | — | CN | disclosed |
| CN-107629059-B | Compounds useful as inhibitors of ATR kinase | 沃泰克斯药物股份有限公司 | 2020-07-28 | — | — | CN | disclosed |
| EP-1803719-A1 | 1,5-DIHETEROCYCLE-1H-TRIAZOLE DERIVATIVE | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2007-07-04 | — | — | EP | disclosed |
| EP-1785418-A1 | PYRAZOLE DERIVATIVE | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2007-05-16 | — | — | EP | disclosed |
| EP-1762568-A1 | PYRAZOLE DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2007-03-14 | — | — | EP | disclosed |
| US-20060189591-A1 | Five-membered heterocyclic derivative | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2006-08-24 | — | — | US | disclosed |
| US-20060128685-A1 | Pyrazole derivative | DAIICHI PHARMACEUTICAL CO., LTD., (JP) | 2006-06-15 | — | — | US | disclosed |
| EP-1621537-A1 | FIVE-MEMBERED HETEROCYCLIC DERIVATIVE | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2006-02-01 | — | — | EP | disclosed |
| EP-1591443-A1 | PYRAZOLE DERIVATIVE | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2005-11-02 | — | — | EP | disclosed |
| US-4428923-A | Continuous process for the production of hydrogen peroxide according to the anthraquinone process | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1984-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060128685-A1 | Pyrazole derivative | PTGS1, PTGS2, PTGER1 | SLC6A2 3642/4885SLC6A4 1980/4885SLC6A3 3044/4885 |
| US-20060189591-A1 | Five-membered heterocyclic derivative | PTGS1, PTGIS, PTGS2 | SLC6A2 3753/4885SLC6A4 2607/4885SLC6A3 3980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.